Evaluation of IL 12 Gene Expression and Serum Levels of OxPL / apoB in Patients with Coronary Artery Disease
Open Access
- 1 August 2024
- journal article
- Published by Scifiniti Publishing
- Vol. 1 (1) , 1-10
Abstract
Background Atherosclerotic lesions are formed as a result of low-density lipoprotein (LDL) accumulation, which is produced by oxidizing enzymes and oxidized phospholipids (OxPL). Phospholipid oxide causes inflammation-inducing activation genes and hyper-inflammation in addition to the initiation of inflammation and expression of Th1 cytokines. Interleukin 12 (IL-12) is one of the most significant stimulants of inflammation and immune responses, among the Th1cytokines. Therefore, it may play a significant role in contributing to atherosclerosis. The quantitative expression of IL-12 mRNA, along with serum OxPL levels, has been analyzed in patients with coronary artery disease (CAD). Methods: Coronary angiography patients, aged 45 to 65 years and referred with chest pain, were examined. The patients were classified into normal coronary arteries (N = 38) and severe three-vessel involvement coronary arteries (N = 41). Molecular testing was performed using real-time PCR. Also, an ELISA test was used to check the OxPl level. Results Expression of IL12 in Individuals with coronary artery disease was increased but was not statistically significant.Keywords
Funding Information
- Tehran University of Medical Sciences (1860-99-03-1393)
This publication has 34 references indexed in Scilit:
- Modification of lipoprotein metabolism and function driving atherogenesis in diabetesAtherosclerosis, 2024
- Atherosclerosis: current pathogenesis and therapeutic optionsNature Medicine, 2011
- Lipoprotein(a): A Unique Risk Factor for Cardiovascular DiseaseClinics In Laboratory Medicine, 2006
- Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertensionAtherosclerosis, 2006
- Oxidized Phospholipids Predict the Presence and Progression of Carotid and Femoral Atherosclerosis and Symptomatic Cardiovascular DiseaseJACC, 2006
- Increased Th1 activity in patients with coronary artery diseaseCytokine, 2004
- The Role of Interleukin-4 and Interleukin-12 in the Progression of Atherosclerosis in Apolipoprotein E-Deficient MiceThe American Journal of Pathology, 2003
- Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokinesAtherosclerosis, 1999
- Interactive Role of Infection, Inflammation and Traditional Risk Factors in Atherosclerosis and Coronary Artery Disease 11This study was supported in part by a Merit Review grant from the Department of Veterans Affairs Central Office, Washington, D.C.JACC, 1998
- Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammationProgress in Growth Factor Research, 1992